Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal

Comprehensive mutational profiling in advanced systemic mastocytosis

(2013) J. Schwaab et al.   BLOOD

International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis

(2013) J. Gotlib et al.   BLOOD

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis

(2013) José M Morgado et al.   HISTOPATHOLOGY

Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis

(2013) Cristina Teodosio et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

A Case of Systemic Mastocytosis Associated with Acute Myeloid Leukemia Terminating as Aleukemic Mast Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

(2013) Mi Hyun Bae et al.   Annals of Laboratory Medicine

Mast cell leukemia

(2012) S. Georgin-Lavialle et al.   BLOOD

Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor

(2012) Sophie Georgin-Lavialle et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression

(2012) Srdan Verstovsek   EUROPEAN JOURNAL OF HAEMATOLOGY

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes

(2012) J J M van Dongen et al.   LEUKEMIA

Mastocytosis and related disorders

(2012) April Chiu et al.   SEMINARS IN DIAGNOSTIC PATHOLOGY

A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib

(2011) Andrzej Mital et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor β chain and KIT V654A

(2011) M S Spector et al.   LEUKEMIA

Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms

(2011) Peter Valent et al.   LEUKEMIA & LYMPHOMA

Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: A diagnostic challenge

(2010) Angela R. Arredondo et al.   AMERICAN JOURNAL OF HEMATOLOGY

Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis

(2010) T. M. Wilson et al.   HAEMATOLOGICA

Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes

(2010) Cristina Teodosio et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis

(2010) Karl Sotlar et al.   MODERN PATHOLOGY

Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives

(2010) Michel Arock et al.   Expert Review of Hematology

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

(2009) K.-H. Lim et al.   BLOOD

Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies

(2009) A. Pardanani et al.   BLOOD

Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients

(2009) Luis Escribano et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates

(2009) A Tefferi et al.   LEUKEMIA